Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Slideshows

Catch up on the top stories in optometry during the week of June 9-June 13.

Takeaways from this week in optometry: June 9 - June 13

Articles

This new QLS-111 and latanoprost fixed-dose combination (QLS-111-FDC; Qlaris) is in development for the treatment of primary open angle glaucoma, ocular hypertension, and normal tension glaucoma for patients whom optimal intraocular pressure control may remain “unachievable” due to needing to lower episcleral venous pressure.

Qlaris Bio announces development of QLS-111-FDC

Anthem will also be required to conduct quarterly self-audits beginning in July of this year in order to document the correction of the issues stated in the report. 

Anthem agrees to pay $100,000 civil penalty following complaint filed in part by Maine Optometric Association

Videos

Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.

What you missed in glaucoma, dry eye, myopia, and more at CCS 2025

Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times – Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

Optometry Times® delivers easily digested, practical information by ODs for ODs that can be immediately applied to improve the clinical experience as well as practice performance. OD provides data, analysis, tools and resources through multichannel touchpoints.

Test

1rem

Strategic Alliance Partners

An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

Atropine vs spectacles: Which move will be more powerful in the game of myopia management?

The American Academy of Orthokeratology & Myopia Control-hosted conference was held September 5-9.

Vision By Design 2023 brought comprehensive myopia management and ortho-k education

The annual conference will take place September 6-9 at the Renaissance Schaumburg Convention Center in Schaumburg, IL.

Vision by Design Conference 2023 announced by the American Academy of Orthokeratology and Myopia Control

Welcome to the American Academy of Orthokeratology & Myopia Control. We are a non-profit organization that supports, promotes and advances the science of orthokeratology and myopia control through quality education and scientific information.

AAOMC

AAOMC | Strategic Alliance Partners

Latest from AAOMC